{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:20:23Z","timestamp":1795123223556,"version":"4.10.3"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate mifepristone, a progesterone receptor antagonist, for labor induction and cesarean delivery and related measures of maternal and neonatal safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis of randomized controlled trials was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) 2020 guidelines and registered in PROSPERO (CRD420251236886). MEDLINE, Embase, ClinicalTrials.gov, and Scopus were searched through October 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>Eligible studies included randomized trials evaluating mifepristone for labor induction in singleton pregnancies at 37 weeks or more of gestation. Studies involving pregnancy termination, intrauterine fetal death, preterm induction, or concomitant cervical ripening interventions in which the effects of mifepristone could not be isolated were excluded. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane Risk of Bias 2 tool. The primary outcome was cesarean delivery. Secondary outcomes included induction-to-delivery interval, time to labor onset, Bishop score, need for prostaglandin or oxytocin, postpartum hemorrhage, neonatal intensive care unit (NICU) admission, and 5-minute Apgar score less than 7. Data were pooled with a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>The primary analysis included all 15 eligible randomized controlled trials across mifepristone dosing regimens (n=1,063) and control conditions (n=811). Mifepristone was associated with 33% reduced odds of cesarean delivery (33.1% vs 41.9%, odds ratio 0.67, 95% CI, 0.54\u20130.82) compared with the control method of induction. Mifepristone was associated with higher Bishop scores at 24 hours, shorter induction-to-delivery intervals, and less prostaglandin and oxytocin use compared with control methods. Findings were similar in sensitivity analysis limited to placebo-controlled and high-quality trials (cesarean delivery odds ratio 0.58, 95% CI, 0.40\u20130.83). No differences were observed in postpartum hemorrhage, NICU admission, or low Apgar score, although most studies did not report these outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Use of mifepristone for labor induction was associated with reduced odds of cesarean delivery, as well as improved cervical ripening and labor induction efficiency. No evidence of short-term maternal or neonatal risk was found, although robust data were limited. Findings support the role of progesterone antagonists for labor induction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO, CRD420251236886.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006450","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:00:29Z","timestamp":1792526429000},"page":"767-780","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Progesterone Receptor Antagonists for Labor Induction"],"prefix":"10.1097","volume":"148","author":[{"given":"Isabelle R.","family":"Pellot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Darch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo W.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise N.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"R2-20261119","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-0528.1988.tb06840.x","article-title":"The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin","volume":"95","author":"Swahn","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"R3-20261119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ando.2016.04.025","article-title":"Endocrinology of human parturition","volume":"77","author":"Vannuccini","year":"2016","journal-title":"Ann Endocrinol"},{"key":"R4-20261119","first-page":"CD002865","article-title":"Mifepristone for induction of labour","author":"Hapangama","year":"2009","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R5-20261119","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"R6-20261119","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jog.14010","article-title":"Safety and efficacy of mifepristone versus dinoprostone gel in induction of labor: a randomized controlled trial","volume":"45","author":"Jindal","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"R7-20261119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.05.084","article-title":"Use of mifepristone to ripen the cervix and induce labor in term pregnancies","volume":"192","author":"Berkane","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20261119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-017-4431-8","article-title":"Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial","volume":"296","author":"Sharma","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"R9-20261119","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejogrb.2024.12.035","article-title":"Mifepristone versus Foley balloon catheter for outpatient cervical ripening at term: a non-inferiority randomised controlled trial","volume":"305","author":"Carvalho-Alfonso","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R10-20261119","first-page":"804","article-title":"The effects of mifepristone on cervical ripening and labor induction in primigravidae","volume":"92","author":"Elliott","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R11-20261119","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1471-0528.1994.tb13150.x","article-title":"Mifepristone for labour induction after previous caesarean section","volume":"101","author":"Lelaidier","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"R12-20261119","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5005\/jp-journals-10006-1893","article-title":"Comparative study of mifepristone with dinoprostone gel in induction of labor in full-term pregnancy: an open-label randomized controlled trial","volume":"13","author":"Kumari","year":"2021","journal-title":"J SAFOG"},{"key":"R13-20261119","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5005\/jp-journals-10006-2186","article-title":"Cervical ripening using mifepristone before induction of labor in term pregnancy: prospective randomized comparative Study","volume":"15","author":"Sharma","year":"2023","journal-title":"J SAFOG"},{"key":"R14-20261119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13224-014-0584-6","article-title":"Safety and efficacy of oral mifepristone in pre-induction cervical ripening and induction of labour in prolonged pregnancy","volume":"65","author":"Yelikar","year":"2015","journal-title":"J Obstet Gynaecol India"},{"key":"R15-20261119","first-page":"e71632","article-title":"Role of mifepristone in induction of labor in full-term pregnancy","volume":"16","author":"Boipai","year":"2024","journal-title":"Cureus"},{"key":"R16-20261119","first-page":"543","article-title":"Mifepristone for preinduction cervical ripening beyond 41 weeks' gestation: a randomized controlled trial","volume":"96","author":"Wing","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R17-20261119","first-page":"793","article-title":"Induction of labor with mifepristone\u2014a randomized, double-blind study versus placebo","volume":"78","author":"Stenlund","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-20261119","first-page":"972","article-title":"Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study","volume":"80","author":"Frydman","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R20-20261119","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2007-0077","article-title":"Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A","volume":"92","author":"Merlino","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20261119","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/molehr\/7.9.875","article-title":"Interactions between progesterone receptor isoforms in myometrial cells in human labour","volume":"7","author":"Pieber","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"R22-20261119","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/MCB.20.9.3102-3115.2000","article-title":"The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding","volume":"20","author":"Giangrande","year":"2000","journal-title":"Mol Cel Biol"},{"key":"R23-20261119","first-page":"e65450","article-title":"Safety and efficacy of oral mifepristone for cervical ripening and induction of labor","volume":"16","author":"Pharande","year":"2024","journal-title":"Cureus"},{"key":"R24-20261119","first-page":"487","article-title":"Cervical ripening with mifepristone before labor induction: a randomized study","volume":"92","author":"Giacalone","year":"1998","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:01:05Z","timestamp":1795122065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006450"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006450","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"2026-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}